A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis
Ruth J. Pepper(University College Hospital), Alan D. Salama(The Royal Free Hospital), Megan Griffith(Imperial College Healthcare NHS Trust), Dearbhla Kelly(John Radcliffe Hospital), Jack Galliford(Imperial College Healthcare NHS Trust), Jeremy Levy(Imperial College Healthcare NHS Trust), Sarah Moran, Jennifer Scott(Tallaght University Hospital), Stephen P. McAdoo(Imperial College Healthcare NHS Trust), Rachel Jones(University of Cambridge), David Jayne(University of Cambridge), Seerapani Gopaluni(CARE Hospitals), Charles D. Pusey(Imperial College Healthcare NHS Trust), Mark A. Little(Trinity College Dublin), Thomas Cairns(Hammersmith Hospital), Áine Burns(The Royal Free Hospital), Sally Hamour(Imperial College London)
Cited by 95
Related Papers
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
|New England Journal of Medicine|2010|1.7k
Avacopan for the Treatment of ANCA-Associated Vasculitis
|New England Journal of Medicine|2021|957
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726